BusinessCrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical ResearchBy Nasdaq OMXAug 1, 2017, 12:00 PM UTC
BusinessAxsome Therapeutics Announces AXS-06 (MoSEIC™ Meloxicam and Esomeprazole) Meets Primary Endpoint in Phase 1 Clinical TrialBy Nasdaq OMXJul 25, 2017, 11:01 AM UTC
BusinessCoherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY)By Nasdaq OMXJan 11, 2016, 11:45 AM UTC
